LAUREN CLIFTON: Open Payments
NPI 1326664541 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,522 in 86 payments from 17 companies in 2025. Trend: 2023 $467 · 2024 $1,403 · 2025 $1,522
Food & beverage: $1,522
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $366 |
| ABBVIE INC. | 22 | $229 |
| AstraZeneca Pharmaceuticals LP | 9 | $201 |
| Lilly USA, LLC | 8 | $164 |
| Exact Sciences Corporation | 5 | $96 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $85 |
| SHIELD THERAPEUTICS INC | 3 | $65 |
| Phathom Pharmaceuticals, Inc. | 4 | $61 |
| Lundbeck LLC | 3 | $46 |
| Axsome Therapeutics, Inc. | 2 | $42 |
Products named: MOUNJARO, Ozempic, Wegovy, FARXIGA, QULIPTA, The Cologuard Plus Collection Kit, Kerendia, AIRSUPRA.
Industry payments across AL — which companies pay providers there.
